134 related articles for article (PubMed ID: 17415108)
1. The use of p16 as a marker for cervical cancer precursor lesions.
O'Connor DM
J Low Genit Tract Dis; 2007 Apr; 11(2):67-8. PubMed ID: 17415108
[No Abstract] [Full Text] [Related]
2. [Comparison of efficacy of combined use of liquid cytology and immunohistochemical assay of p16ink4 and standard procedure and high risk evaluation by polymerase chain reaction of human papillomavirus infection in diagnosing cervical dysplasia and carcinoma].
Raskin GA; Petrov SV; Orlova RV; Mal'tseva LI; Akhmetzianova AV; Farrakhova LN; Khasanov RSh
Vopr Onkol; 2009; 55(2):192-5. PubMed ID: 19514374
[TBL] [Abstract][Full Text] [Related]
3. [Genetic diagnosis of cervical cancer].
Sasagawa T
Nihon Rinsho; 2004 Oct; 62 Suppl 10():103-8. PubMed ID: 15535215
[No Abstract] [Full Text] [Related]
4. P16 as a molecular biomarker of cervical adenocarcinoma.
Schorge JO; Lea JS; Elias KJ; Rajanbabu R; Coleman RL; Miller DS; Ashfaq R
Am J Obstet Gynecol; 2004 Mar; 190(3):668-73. PubMed ID: 15041997
[TBL] [Abstract][Full Text] [Related]
5. [Interest of new biomarkers in cervical precancerous lesion management].
Dachez R
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S152-4. PubMed ID: 18191337
[TBL] [Abstract][Full Text] [Related]
6. Translational approaches to improving cervical screening.
Baldwin P; Laskey R; Coleman N
Nat Rev Cancer; 2003 Mar; 3(3):217-26. PubMed ID: 12612656
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of p16 for differentiating primary pulmonary squamous cell carcinoma from cervical squamous cell carcinoma metastatic to the lung.
Wang CW; Wu TI; Yu CT; Wu YC; Teng YH; Chin SY; Lai CH; Chen TC
Am J Clin Pathol; 2009 May; 131(5):715-22. PubMed ID: 19369633
[TBL] [Abstract][Full Text] [Related]
8. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions.
Shi J; Liu H; Wilkerson M; Huang Y; Meschter S; Dupree W; Schuerch C; Lin F
Hum Pathol; 2007 Sep; 38(9):1335-44. PubMed ID: 17512033
[TBL] [Abstract][Full Text] [Related]
10. Functional biomarkers in cervical precancer: an overview.
Gupta N; Srinivasan R; Rajwanshi A
Diagn Cytopathol; 2010 Aug; 38(8):618-23. PubMed ID: 19941372
[TBL] [Abstract][Full Text] [Related]
11. [Cell protein p16INK4a hyperexpression in epithelial malignancies induced by human papillomaviruses].
Volgareva GM; Zavalishina LE; Andreeva IuIu; Shtil' AA; Frank GA
Arkh Patol; 2008; 70(5):57-61. PubMed ID: 19137788
[TBL] [Abstract][Full Text] [Related]
12. Assessment of potential of AgNOR counts as tumor marker in cervical carcinogenesis.
Misra JS; Chhavi ; Singh M; Srivastava AN; Das V
Diagn Cytopathol; 2008 Mar; 36(3):194-5. PubMed ID: 18232010
[No Abstract] [Full Text] [Related]
13. p16, p14, p53, and Cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix by Horn et al.
Herrington CS
Int J Gynecol Pathol; 2006 Oct; 25(4):408. PubMed ID: 16990721
[No Abstract] [Full Text] [Related]
14. [Detection of regulatory protein p16/INK4A in the dysplastic cervical squamous cell epithelium is a diagnostic tool for carcinoma prevention].
Rajcáni J; Adamkov M; Hybenová J; Moráveková E; Lauko L; Felcanová D; Bencat M
Cesk Patol; 2009 Oct; 45(4):101-7. PubMed ID: 20301837
[TBL] [Abstract][Full Text] [Related]
15. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
Duncan L; Jacob S; Hubbard E
Cancer; 2008 Feb; 114(1):34-48. PubMed ID: 18186493
[TBL] [Abstract][Full Text] [Related]
17. Cervical screening in genitourinary medicine clinics--what are we trying to achieve?
Bradbeer C; Navaratne L
Sex Transm Infect; 1999 Oct; 75(5):286-7. PubMed ID: 10616349
[No Abstract] [Full Text] [Related]
18. [HPV TEST SCREENING FOR THE DETECTION OF PRECANCEROUS CERVICAL LESIONS AND CERVICAL CANCER].
Schejter E; Segal J
Harefuah; 2018 Nov; 157(11):704-706. PubMed ID: 30457233
[No Abstract] [Full Text] [Related]
19. [Precancerous lesions of the uterine cervix].
Purola E
Duodecim; 1985; 101(15):1496-503. PubMed ID: 4042903
[No Abstract] [Full Text] [Related]
20. [Biomarkers and uterine cervical cancer. Are they useful for prognosis of cancer and triage of precancerous lesions?].
Salvat J; Schmidt MH; Vincent-Genod A; Slamani L; Martino A
Contracept Fertil Sex; 1999; 27(7-8):521-31. PubMed ID: 10495569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
